Olanzapine
Treatment for Frontotemporal Dementia
Typical Dosage: 2.5-10mg daily
Effectiveness
70%
Safety Score
40%
Clinical Trials
15
Participants
800
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-10mg daily
Time to Effect
Days to weeks
Treatment Duration
Short-term or lowest effective dose, long-term monitoring
Evidence Quality
MODERATENumber Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
55%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$250
Side Effect Mgmt:$750
Total Annual:$1,075
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$1,791.67
Olanzapine Outcomes
for Frontotemporal Dementia
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Common Side Effects
Sedation
+30%
Weight gain
+20%
Metabolic changes
+15%
Extrapyramidal symptoms
+10%
Increased risk of stroke/TIA
+2%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov